subject area of

• ATF6-Mediated Signaling Contributes to PARP Inhibitor Resistance in Ovarian Cancer  Journal Article
• Lived experiences of women reporting fatigue during PARP inhibitor maintenance treatment for advanced ovarian cancer: A qualitative study  Journal Article
• Rapid evolution of BRCA1 and BRCA2 in humans and other primates  Journal Article
• The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval  Journal Article